Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

GAP1m Inhibitors

GAP1m inhibitors are a class of chemical compounds that specifically target and modulate the activity of GTPase-activating proteins (GAPs) associated with the Ras family of GTPases. GAPs are essential regulatory proteins that facilitate the hydrolysis of GTP to GDP, effectively turning off the active signaling state of Ras GTPases. The Ras family of proteins, including H-Ras, K-Ras, and N-Ras, plays a critical role in cellular signaling pathways, particularly those involved in cell proliferation, differentiation, and survival. GAP1m, or GAP1 family member 1, is a specific GAP that acts on multiple members of the Ras family, and its inhibition can lead to prolonged Ras activation. This prolonged activation is essential for studying Ras-dependent signaling pathways and understanding the precise molecular mechanisms that underlie Ras-mediated cellular processes. The design and synthesis of GAP1m inhibitors involve the development of molecules that can selectively bind to the active site or regulatory regions of the GAP1m protein, thereby preventing its interaction with Ras proteins. This inhibition can be achieved through various structural motifs and binding strategies, including small molecules, peptides, and synthetic analogs. The chemical diversity within this class of inhibitors allows for fine-tuning of their affinity, selectivity, and specificity towards GAP1m. Additionally, studying these inhibitors provides insights into the structural and functional dynamics of the Ras-GAP interaction. By modulating GAP1m activity, researchers can dissect the complex signaling networks regulated by Ras proteins and explore their role in various cellular processes. The exploration of GAP1m inhibitors contributes to a broader understanding of GTPase regulation and the intricate balance of signaling events within cells.

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Manumycin A

52665-74-4sc-200857
sc-200857A
1 mg
5 mg
$219.00
$634.00
5
(1)

It inhibits farnesyl transferase, thereby preventing prenylation of Ras proteins and blocking their activation. RASA2's action is consequently magnified.

Farnesyl thiosalicylic acid

162520-00-5sc-205322
sc-205322A
1 mg
5 mg
$61.00
$82.00
15
(1)

FTS disrupts the association between RAS and the membrane, effectively incapacitating RAS activation and thus bolstering RASA2's GTPase-activating function.

GGTI 298

1217457-86-7sc-361184
sc-361184A
1 mg
5 mg
$193.00
$838.00
2
(1)

Inhibits geranylgeranyltransferase I and interferes with RAS membrane localization. By preventing RAS activation, it indirectly strengthens RASA2's action.

Zoledronic acid, anhydrous

118072-93-8sc-364663
sc-364663A
25 mg
100 mg
$92.00
$256.00
5
(0)

It inhibits prenylation of proteins, including Ras, thus causing Ras to remain in its GDP-bound state, accentuating RASA2's function.

Lonafarnib

193275-84-2sc-482730
sc-482730A
5 mg
10 mg
$173.00
$234.00
(0)

This chemical inhibits farnesyl transferase and blocks RAS activation, indirectly increasing the effectiveness of RASA2.

Tipifarnib

192185-72-1sc-364637
10 mg
$720.00
(0)

A farnesyl transferase inhibitor that stops RAS activation. This inhibition enhances RASA2's GTPase-activating function.

GDC-0941

957054-30-7sc-364498
sc-364498A
5 mg
10 mg
$188.00
$199.00
2
(1)

PI3K inhibitor that reduces AKT phosphorylation, indirectly affecting Ras activity. This supports the GAP1m's GTPase activity by limiting Ras activation.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

MEK inhibitor that blocks ERK phosphorylation, a downstream effector of Ras. Inhibition here allows RASA2 to more effectively convert Ras-GTP to Ras-GDP.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Another MEK inhibitor. By reducing ERK phosphorylation, RASA2's GAP activity on Ras-GTP is indirectly enhanced.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor that attenuates AKT phosphorylation, thereby disrupting RAS signaling and subsequently enhancing RASA2 function.